Perceptive Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Perceptive Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,429	Closed	-$491K	–	205
2016 Q1	$491K	Buy	3,429 +1,936	+130%	+$275K	0.04%	129
2015 Q4	$231K	Hold	1,493	–	–	0.02%	118
2015 Q3	$213K	Hold	1,493	–	–	0.02%	128
2015 Q2	$215K	Sell	1,493 -32,081	-96%	-$4.58M	0.01%	159
2015 Q1	$4.74M	Sell	33,574 -120,454	-78%	-$18.5M	0.37%	53
2014 Q4	$22.8M	Buy	154,028 +13,093	+9%	+$1.92M	1.91%	16
2014 Q3	$21.7M	Sell	140,935 -160,398	-53%	-$24.1M	2.19%	13
2014 Q2	$42.3M	Buy	301,333 +204,322	+211%	+$22.7M	4.15%	6
2014 Q1	$10.8M	Buy	97,011 +40,409	+71%	+$4.4M	1.13%	28
2013 Q4	$5.6M	Buy	+56,602	New	+$4.91M	0.67%	34

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Perceptive Advisors's TARO Position: Q2 2016 in Review

Perceptive Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 3,429 shares — an estimated $491K sold.

Perceptive Advisors first reported a position in TARO in Q4 2013 and held it in 10 quarters. The position peaked at $42.3M in Q2 2014. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Perceptive Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Perceptive Advisors sold 3,429 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $491K.
Perceptive Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2013 and held it in 10 quarters.
Perceptive Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $42.3M in Q2 2014.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Perceptive Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.